Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA   US04033A1007

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/25/2015 06/26/2015 06/29/2015 06/30/2015 07/01/2015 Date
8.69(c) 8.435(c) 7.9(c) 8.27(c) 8.09(c) Last
1 568 392 3 806 874 3 721 305 2 944 150 2 591 373 Volume
0.00% -2.93% -6.34% +4.68% -2.18% Change
More quotes
Financials ($)
Sales 2015 145 M
EBIT 2015 -190 M
Net income 2015 -201 M
Finance 2015 43,9 M
Yield 2015 -
Sales 2016 221 M
EBIT 2016 -137 M
Net income 2016 -139 M
Debt 2016 26,9 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 10,2x
EV / Sales 2016 7,03x
Capitalization 1 526 M
More Financials
Company
ARIAD Pharmaceuticals, Inc. operates as an oncology company which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.Its products includes Iclusig (ponatinib), Brigatinib (previously known as AP26113), and AP32788.The company was founded... 
Sector
Pharmaceuticals
Calendar
08/05Earnings Release
More about the company
Surperformance© ratings of Ariad Pharmaceuticals, Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ARIAD PHARMACEUTICALS, INC
06/24 ARIAD PHARMACEUTICALS : Announces Long-Term Safety and Efficacy Data of Ponatini..
06/22 ARIAD PHARMACEUTICALS : and Paladin Enter into Commercial Distribution Agreement..
06/21 ARIAD PHARMACEUTICALS : Updates on Long-Term Safety and Efficacy Data of Ponatin..
06/17 ARIAD PHARMACEUTICALS : to Present at the Goldman Sachs Annual Global Healthcare..
06/17 ARIAD PHARMACEUTICALS : and Paladin Announce Commercial Distribution Agreement f..
06/17 ARIAD PHARMACEUTICALS : Updates on Long-Term Safety and Efficacy Data of Ponatin..
06/17 ARIAD PHARMACEUTICALS : Updates on Long-Term Safety and Efficacy Data of Ponatin..
06/12 ARIAD PHARMACEUTICALS : Announces Long-Term Safety and Efficacy Data of Ponatini..
More news
Sector news : Biopharmaceuticals
03:34aDJErgomed Appoints Andrew Mackie as Chief Business Officer
03:01a PFIZER : ViiV Healthcare : and Desano Pharmaceuticals' Manufacturing Agreement W..
01:07a ASTRAZENECA : *berenberg raises astrazeneca to 'buy' ('hold') - price target 520..
More sector news : Biopharmaceuticals
News from SeekingAlpha
06/12 ARIAD's Iclusig delivers long-term therapeutic benefit in blood cancer patien..
05/07 ARIAD Pharmaceuticals (ARIA) Harvey J. Berger on Q1 2015 Results - Earnings C..
05/07 Ariad Pharma reports Q1 results
05/07 ARIAD Pharmaceuticals (ARIA) Q1 2015 Results - Earnings Call Webcast
05/07 ARIAD Pharmaceuticals misses by $0.01, misses on revenue


Comments 
Advertisement
Chart ARIAD PHARMACEUTICALS, INC
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | ARIA | US04033A1007 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions